Indefinite Delivery Contract SPE2DX15D9136
- Not listed
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the medical needs of military healthcare facilities worldwide. This IDC, awarded under the SPE2DX program, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter...
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This IDC, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. Through this contract, DMS Pharmaceutical...
- This single-award Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,999,999.99, has an ultimate completion date of December 31, 2025 and enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an...
- This single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DX program aims to provide the U.S. Department of Defense (DoD) with a comprehensive range of pharmaceutical products and medical supplies. The prime contractor, DMS Pharmaceutical Group Inc., is a woman-owned small business based in Park Ridge, Illinois, that specializes in federal government pharmaceutical procurement. The IDC, valued at $4,999,999, covers a diverse portfolio of branded...
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, under the SPE2DB program. The IDC, valued at $499,999,999 and valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- This single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DX program is held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4.9 million contract, which does not utilize any set-asides, covers a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The task orders issued under this...
- This single-award indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $4,999,999.00 contract, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The IDC enables DMS Pharmaceutical Group to provide a...
- The Indefinite Delivery Contract (IDC) awarded to DMS Pharmaceutical Group Inc. by the Defense Logistics Agency (DLA) under the SPE2DX program is a single-award contract valued at $499,999,999 and valid through November 2026. This contract enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs...
- The Defense Logistics Agency (DLA) awarded an Indefinite Delivery Contract (IDC) valued up to $4,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to military health facilities worldwide. The IDC, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. Notable...
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 IDC, awarded under the SPE2DB program, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables....
- SPE2DX15D9136Indefinite Delivery Contract
- 82Federal Contract Awards
This single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DX program enables the procurement of a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The prime contractor, DMS Pharmaceutical Group Inc., is a woman-owned small business pharmaceutical wholesaler that provides branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to the Department of Defense. The $4,999,999 contract has a period of performance through December 31, 2025 and allows the DLA to issue firm fixed-price delivery orders for items across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract position DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, facilitating direct distribution of prescription drugs and pharmacy services to DoD healthcare sites with no set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 4/13/15 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order SPE2DX15D9136-SPE2DX20FV64P | DMS Pharmaceutical Group Inc. | $340 | 3/16/20 | 3/17/20 | 3/16/20 | |
Delivery Order SPE2DX15D9136-SPE2DX19FV64X | DMS Pharmaceutical Group Inc. | $3.7k | 7/31/19 | 8/21/19 | 7/31/19 | |
Delivery Order SPE2DX15D9136-SPE2DX20FV64S | DMS Pharmaceutical Group Inc. | $407 | 4/14/20 | 4/15/20 | 4/14/20 | |
Delivery Order SPE2DX15D9136-SPE2DX19FV64B | DMS Pharmaceutical Group Inc. | $3.6k | 12/18/18 | 1/11/19 | 12/18/18 | |
Delivery Order SPE2DX15D9136-SPE2DX19FV64T | DMS Pharmaceutical Group Inc. | $205 | 6/28/19 | 7/1/19 | 6/28/19 |